Trade Moderna Inc - MRNA CFD

Add to favourite

30.97

2.79%

0.17

Low: 30.97

High: 32.04

Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Thu: 08:00 - 00:00

Fri: 08:00 - 21:00

Summary
Historical Data

Trading сonditions

Spread

0.17

Long position overnight fee

-0.02354%

Short position overnight fee

0.001318%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	31.86
Open	31.86
1-Year Change	-71.18%
Day's Range	30.97 - 32.04

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Mar 28, 2025	30.97	-0.58	-1.84%	31.55	32.41	30.96
Mar 27, 2025	32.00	0.58	1.85%	31.42	32.49	31.20
Mar 26, 2025	31.27	-2.08	-6.24%	33.35	33.80	31.23
Mar 25, 2025	33.82	-0.28	-0.82%	34.10	34.78	33.45
Mar 24, 2025	34.12	1.42	4.34%	32.70	34.80	32.70
Mar 21, 2025	32.55	0.10	0.31%	32.45	32.73	31.46
Mar 20, 2025	32.48	-0.60	-1.81%	33.08	33.75	32.38
Mar 19, 2025	33.31	-0.19	-0.57%	33.50	33.78	33.06
Mar 18, 2025	33.71	-0.79	-2.29%	34.50	34.92	33.44
Mar 17, 2025	34.65	0.08	0.23%	34.57	35.10	33.85
Mar 14, 2025	34.56	0.26	0.76%	34.30	35.77	33.95
Mar 13, 2025	34.28	0.03	0.09%	34.25	38.02	33.90
Mar 12, 2025	34.95	1.60	4.80%	33.35	35.22	33.35
Mar 11, 2025	33.65	-1.70	-4.81%	35.35	37.00	32.56
Mar 10, 2025	35.27	-0.32	-0.90%	35.59	37.92	35.05
Mar 7, 2025	35.46	1.31	3.84%	34.15	37.85	33.87
Mar 6, 2025	34.15	-0.88	-2.51%	35.03	35.26	33.06
Mar 5, 2025	34.95	3.30	10.43%	31.65	35.32	30.85
Mar 4, 2025	31.70	1.50	4.97%	30.20	31.72	29.20
Mar 3, 2025	30.25	-0.23	-0.75%	30.48	31.92	30.10

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Moderna, Inc. Company profile

Get all the information you need on the Moderna stock price today with Capital.com’s comprehensive chart.

Moderna (MRNA) is a North American clinical-stage biotechnology company. Headquartered in Cambridge, Massachusetts, it specialises in drug discovery and development, as well as vaccine technologies based on messenger RNA (mRNA). The company is working on therapeutics and vaccines for infectious, autoimmune, immuno-oncology and cardiovascular diseases.

Moderna has a number of strategic partnerships with industry-leading names, such as Vertex Pharmaceuticals (VRTX), AstraZeneca (AZN) and Merck & Co (MRK). In 2020, it also worked with Lonza Group (LONN) and Catalent (CTLT) to manufacture its Covid-19 vaccine candidate mRNA-1273. At the end of 2020, the company had 12 programmes in clinical trials and a total of 23 development candidates.

Moderna shares are listed on the Nasdaq Stock Market under the ticker symbol MRNA. The company is a constituent of the US Tech 100 Index.

Stay up-to-date with the latest market news and watch the Moderna share price live at Capital.com.

The company was founded in 2010 as Moderna Therapeutics, with the goal of commercialising the research of stem-cell biologist Derrick Rossi. Apart from Rossi, Moderna’s co-founders were Noubar Afeyan, Robert Langer and Kenneth Chien. In August 2018, the company’s name was changed to Moderna.

In November 2020, Moderna’s Covid-19 vaccine candidate, mRNA-1273, showed preliminary evidence of 94.1 per cent efficacy in preventing the disease in a Phase 3 trial. The results led to its submission for emergency use authorisation in the US, Canada and Europe.

In late November, the EU made a deal with Moderna for up to 160 million doses of its vaccine. In December, the US government exercised its option to buy an additional 100 million doses of Moderna’s mRNA-1273, bringing the confirmed order commitment to 200 million doses.

With Capital.com’s Moderna share price chart, you can not only quickly view the current MRNA stock quote, but also trace the company’s share value in historic terms.

Moderna’s long-awaited initial public offering (IPO) happened in December 2018, with the firm selling 26.3 million shares priced at $23 each. At the time, it was the biggest biotech IPO ever. Moderna raised over $600m, valuing the company at $7.5bn (£5.6bn, €6.2bn).

In 2020, MRNA stock has been one of the US market’s best performers. This was due to rising investor enthusiasm over the company’s promising Covid-19 vaccine candidate. After opening the year at $19.57, the MRNA share price was on a hike, peaking at $94.85 in mid July. Within a month, it had dropped to $54.23, but then the stock gained another upside momentum, with its price surging past $100 on November 16. On December 8, the stock closed the trading day at $169.86, representing a year-to-date gain of nearly 770 per cent.

You can go long or short on the company’s shares and trace all the latest ups and downs of the Moderna Inc. stock price using Capital.com’s proprietary trading platform.

Industry:

Biotechnology & Medical Research (NEC)

200 Technology Sq
CAMBRIDGE
MASSACHUSETTS 02139-3578
US